Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ For further information, see CMDT Part 20-23: Levamisole-Associated Purpura +++ Key Features ++ Levamisole is a prevalent adulterant of illicit cocaine in North America Exposure can induce a distinctive clinical syndrome of retiform purpura and cutaneous necrosis affecting the Extremities Ears Skin overlying the zygomatic arch Long-term sequelae of levamisole exposure include Deforming cutaneous lesions Arthralgias Arthritis +++ Clinical Findings ++ The syndrome is associated with The lupus anticoagulant IgM antibodies to cardiolipin Very high titers of p-ANCAs (due to autoantibodies to elastase, lactoferrin, cathepsin-G, and other neutrophil components rather than to myeloperoxidase alone) Use of levamisole-adulterated cocaine also has been linked to Neutropenia Agranulocytosis Pauci-immune glomerulonephritis +++ Diagnosis ++ Biopsies reveal widespread thrombosis of small cutaneous vessels with varying degrees of vasculitis +++ Treatment ++ There is no consensus on treatment, but early lesions can resolve with abstinence Your Access profile is currently affiliated with '[InstitutionA]' and is in the process of switching affiliations to '[InstitutionB]'. Please click ‘Continue’ to continue the affiliation switch, otherwise click ‘Cancel’ to cancel signing in. Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Username Error: Please enter User Name Password Error: Please enter Password Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth